Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer.
Laia GorchsCarlos Fernandez MoroEbba AsplundMarlies OosthoekMartin SoldersPoya GhorbaniErnesto SparrelidElena RangelovaJohannes Matthias LöhrHelen KaipePublished in: Cancer research communications (2024)
Patients with pancreatic cancer with a high proportion of CD39+CD103+ CD8+ T cells exhibiting a tumor-reactive phenotype have improved survival rates, suggesting their potential utility in selecting candidates for immunotherapy trials.